By Scientia Professor Carla Treloar

Journal articles

Henry DA; Henderson KM; Fryer JL; Treloar CJ; McGrath KM; Deveridge SF, 2000, 'Use of interventions to minimise perioperative allogeneic blood transfusion in Australia: A survey by the International Study of Perioperative Transfusion (ISPOT) study group', Medical Journal of Australia, 172, pp. 365 - 369, http://dx.doi.org/10.5694/j.1326-5377.2000.tb124007.x

Mukti AG; Treloar C; Suprawimbarti ; Asdie AH; D'Este K; Higginbotham N; Heller R, 2000, 'A universal precautions education intervention for health workers in Sardjito and PKU Hospital Indonesia', Southeast Asian Journal of Tropical Medicine and Public Health, 31, pp. 405 - 411

Nair BR; Treloar CJ; Harris G, 2000, 'Do we need a new word for patients?', Australian and New Zealand Journal of Medicine, 30, pp. 716 - 717, http://dx.doi.org/10.1111/j.1445-5994.2000.tb04367.x

Boots RJ; Treloar C, 2000, 'Prediction of intern attendance at a seminar-based training programme: A behavioural intention model', Medical Education, 34, pp. 512 - 518, http://dx.doi.org/10.1046/j.1365-2923.2000.00567.x

Evans K; Mayer J; Treloar C, 2000, 'Who cares? A focus group study on follow up care after discharge from hospital.', Australian family physician, 29, pp. 384 - 388

Treloar C; Champness S; Simpson PL; Higginbotham N, 2000, 'Critical appraisal checklist for qualitative research studies', Indian Journal of Pediatrics, 67, pp. 347 - 351

Treloar C; Porteous J; Hassan F; Kasniyah N; Lakshmanudu M; Sama M; Sja'Bani M; Heller RF, 1999, 'The cross cultural context of obesity: An INCLEN multicentre collaborative study', Health and Place, 5, pp. 279 - 286, http://dx.doi.org/10.1016/S1353-8292(99)00018-0

Treloar CJ, 1998, 'Evaluation of a national and international distance education programme in clinical epidemiology', Medical Education, 32, pp. 70 - 75, http://dx.doi.org/10.1046/j.1365-2923.1998.00168.x

Franklin JW, 1998, 'Afterword', Anything goes, pp. 195 - 198

Harris MA; Treloar CJ; Byles JE, 1998, 'Colorectal cancer screening: discussions with first degree relatives.', Aust N Z J Public Health, 22, pp. 826 - 828, http://dx.doi.org/10.1111/j.1467-842x.1998.tb01502.x

Treloar C, 1997, 'Developing a multilevel understanding of heart disease: An interview study of MONICA participants in an Australian center', Qualitative Health Research, 7, pp. 468 - 486, http://dx.doi.org/10.1177/104973239700700403

Treloar CJ, 1996, 'An 'academic detailing' intervention to decrease exposure to HIV infection among health-care workers', Journal of Health Psychology, 1, pp. 455 - 468, http://dx.doi.org/10.1177/135910539600100404

Treloar CJ; Higginbotham N; Malcolm JA; Sutherland DC; Berenger S, 1995, 'The personal experience of Australian health-care workers accidentally exposed to risk of HIV infection [7]', AIDS, 9, pp. 1385 - 1386, http://dx.doi.org/10.1097/00002030-199512000-00018

Treloar CJ; Malcolm JA; Sutherland DC; Berenger S; Higginbotham N, 1994, 'Hospital administrators' tolerance of staff needlestick injuries', Infection Control & Hospital Epidemiology, 15, pp. 307 - 310, http://dx.doi.org/10.1086/646917

Conference Papers

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'How can a new formulation reduce stigma linked to opiate agonist treatment?: Place, time and things in the experience of extended-release buprenorphine depot', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S137 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Clay S; Treloar C; Degenhardt L; Grebely J; Farrell M; Marshall AD, 2022, 'Options: Exploring patients' experiences with depot buprenorphine and their motivations to discontinue', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', in International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Grebely J; Marshall AD, 2021, '"WE'VE HAD A CIRCUIT BREAKER FOR AN OLD DOGMA OF MORE THAN 20 YEARS": CHANGES TO OPIOID AGONIST TREATMENT SERVICES DURING COVID-19, THE CHOICE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2021, 'EXPERIENCES AND EFFECTS OF EXTENDED-RELEASE BUPRENORPHINE DEPOT TREATMENT: QUALITATIVE FINDINGS FROM THE COLAB STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S18 - S18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Amin J; Christmass M; Dunlop AJ; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Dore GJ; Treloar C; Grebely J, 2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelly PJ; Beck AK; Baker AL; Deane FP; Shakeshaft A; Hides L; Manning V; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; Mcglaughlin R, 2021, 'ROUTINE OUTCOME MONITORING AND FEEDBACK IN SMART RECOVERY: FEASABILITY AND ACCEPTABILITY OF "SMART TRACK", AN INNOVATIVE, PURPOSE-BUILT SMART PHONE APP', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barnett A; Savic M; Lintzeris N; Bathish R; Arunogiri S; Dunlop AJ; Haber PS; Graham R; Hayes V; Lubman DI; White B; Doyle M; Little SC; Roberts J; Henderson C; Mcleod L; Harrod ME; Crawford S; Lord S; Lancaster K; Treloar C; Gendera S, 2021, 'SYMPOSIUM: CONSUMER EXPERIENCES OF LONG-ACTING INJECTIBLE BUPRENORPHINE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S17 - S18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Marshall AD; Grebely J; Dore GJ; Treloar C, 2019, 'BARRIERS AND FACILITATORS TO ENGAGING IN HEPATITIS C MANAGEMENT AND DIRECT-ACTING ANTIVIRAL THERAPY AMONG GENERAL PRACTITIONERS AND DRUG AND ALCOHOL SPECIALISTS: THE PRACTITIONER EXPERIENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S9 - S9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rance J; Lafferty L; Treloar C, 2019, 'PROMISE AND PHARMACEUTICALISATION IN THE ERA OF DIRECT-ACTING ANTIVIRALS', Montreal, Cananda, presented at International Symposium on Hepatitis Care in Substance Users, Montreal, Cananda, 11 September 2019 - 13 September 2019

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin N; Mchutchison JG; Brainard D; Treloar C; Lloyd A; Dore G, 2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S187 - S188, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30587-7

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; Mchutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0

Hajarizadeh B; Grebely J; Byrne M; Marks P; Butler T; Amin J; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore G, 2016, 'Hepatitis C virus exposure, infection and associated risk behaviours in two maximum-security prisons in New South Wales, Australia', in HEPATOLOGY, WILEY, MA, Boston, pp. 385A - 386A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016

Lord HL; Newland J; Cama E; Treloar C; Levy MT, 2014, 'Understanding the Phases of Chronic Hepatitis B; the problem and a novel solution using renamed phases, the Hepatitis B Bear and a video (see " Understanding Hepatitis B " on YouTube)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1001A - 1002A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lord H; Treloar C; Cama E; Newland J; Levy MT, 2014, 'Understanding the phases of chronic hepatitis B: the problem and a novel solution using renamed phases, the hepatitis B bear and a video (see "Understanding Hepatitis B" on YouTube)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Treloar C, 2013, '"YOU'VE GOT CONTROL OF THE PUMP": THE IMPORTANCE OF TRUST IN THE DRUG TREATMENT CLINIC', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 3 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Treloar C; Fraser S; Bryant J; Rhodes T; Rance J, 2013, 'UNDERSTANDING AND PREVENTING HEPATITIS C TRANSMISSION WITHIN SEXUAL PARTNERSHIPS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brener L; Resnick I; Ellard J; Treloar C; Bryant J, 2009, 'EXPLORING THE ROLE OF CONSUMER PARTICIPATION IN DRUG TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A5 - A5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fraser S; Bryant J; Treloar C, 2009, 'KEY PRIORITIES IN HEPATITIS C: NEW INSIGHTS FROM SOCIAL RESEARCH', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL PUBLISHING, INC, pp. A71 - A72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300218&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brener L; Treloar C, 2008, 'Alcohol and other drug treatment experiences of hepatitis C positive and hepatitis C negative clients: implications for the roll out of hepatitis C treatment', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A339 - A339, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Treloar C; Fraser S, 2008, 'Hepatitis C treatment in pharmacotherapy services: increasing treatment uptake needs a critical view', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A338 - A339, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Bryant J; Bell S; Bolt R; Graham S; Doyle M; Newman CE; Murphy D; Treloar C; Browne A; Aggleton P; Botfield J; Hardy R; Brown E; Kougelos V; Stanbury L; Brooks M; Beetson K, 2019, 'What we do well – Stories of love, sex and relationship: a project looking at Aboriginal young people’s strengths and resources for building sexual well-being', Darwin, presented at LOWITJA HEALTH AND WELL-BEING CONFERENCE, Darwin, 18 June 2019 - 19 June 2019

Bryant J; Bell S; Bolt R; Graham S; Doyle M; Newman CE; Murphy D; Treloar C; Browne A; Aggleton P; Botfield J; Hardy R; Brown E; Kougelos V; Stanbury L; Brooks M; Beetson K, 2018, 'Fostering the sexual well-being of Aboriginal young people by building on social, cultural and personal strengths and resources', Auckland, presented at IUSTI AP SEXUAL HEALTH CONGRESS 2018, Auckland, 01 November 2018 - 03 November 2018

Lafferty LM; Rance J; Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017

Rance JA; Lafferty L; Treloar C, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015

Rance JA; Treloar C; Rhodes T; Bryant J; Fraser S, 2015, '"It’s not only my life I got to worry about"’: accounts of needle-syringe sharing and negotiated safety among couples who inject drugs.', Manly, Sydney, presented at 4th International Symposium on Hepatitis Care in Substance Use, Manly, Sydney, 07 October 2015 - 09 October 2015

Conference Presentations

Lafferty L; Bryant J; Mao L; Hull P; Gray R; Treloar C, 2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019

Lafferty L; Rance J; Treloar C, 2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019

Rance J; Lafferty L; Treloar C, 2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018

Rance J; Lafferty L; Treloar C, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018

Broady T; Cama E; Brener L; Hopwood M; de Wit J; Treloar C, 2018, 'The National Stigma Indicator Project: Key findings and lessons regarding people living with HCV and people who inject drugs', presented at Australasian Viral Hepatitis Conference, Adelaide, 13 August 2018 - 15 August 2018

Lafferty LM; Rance J; Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017

Back to profile page